Wegovy (semaglutide 2.4) and Zepbound (tirzepatide) are recent breakthroughs, enabling average weight losses of 1520% in clinical trials
Since the expiry of the patent, several Indian drug makers have rolled out generic semaglutide products, with monthly injections costing anywhere between 1,300 rupees to 4,200 rupees (US$15-US$45)
But to really understand the GLP-1 revolution, we have to look inside the brain
There are clearly observable patterns: doses that keep appearing across unrelated users, cycle lengths that cluster around specific injury types, and timing decisions that reflect real physiological consistency
Elevated insulin stimulates ovarian androgen production and disrupts normal LH/FSH pulsatility, leading to anovulation